Structure-based optimization of TEAD inhibitors: Exploring a novel subpocket near Glu347 for the treatment of NF2-mutant cancer

unknow

★ 5.0 · 14 reads

Sign in to save this
Request Code
ZLIB.IO18509564
Published
2022
Pages
1
Language
Unknown